Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M E Desar

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The Netherlands Journal of Medicine|May 17, 2006
Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiencyI M E Desar, M Keuter, J M M Raemaekers, et al.
Cancer Treatment Reviews|January 13, 2009
Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapyI M E Desar, C M L van Herpen, H W M van Laarhoven, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2023
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patientsK Westerdijk, S D Krens, N Steeghs, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 2011
A new, simple and objective prognostic score for phase I cancer patientsL M Füssenich, I M E Desar, M E W J Peters, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Health-related quality of life in patients with gastrointestinal stromal tumor: data from a real-world cohort compared with a normative populationD van de Wal, D den Hollander, I M E Desar, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2019
Analysis of 105.000 patients with cancer: have they been discussed in oncologic multidisciplinary team meetings? A nationwide population-based study in the NetherlandsJ E W Walraven, I M E Desar, J J M Hoeven van der, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 13, 2018
Surgical and medical management of small bowel gastrointestinal stromal tumors: A report of the Dutch GIST registryP A Boonstra, N Steeghs, S Farag, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 26, 2025
Double burden: financial toxicity in patients with advanced soft tissue sarcoma at the start of first-line palliative chemotherapy: baseline data from the HOLISTIC studyE Roets, E Younger, R L Jones, et al.
ESMO Open|December 9, 2022
Sex differences in patients with gastrointestinal stromal tumours: do they exist and does it affect survival?N S IJzerman, E van Werkhoven, M Mohammadi, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 17, 2012
Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot studyI M E Desar, E G W ter Voert, Th Hambrock, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Netherlands Journal of Medicine|May 17, 2006
Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiencyI M E Desar, M Keuter, J M M Raemaekers, et al.
Cancer Treatment Reviews|January 13, 2009
Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapyI M E Desar, C M L van Herpen, H W M van Laarhoven, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2023
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patientsK Westerdijk, S D Krens, N Steeghs, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 2011
A new, simple and objective prognostic score for phase I cancer patientsL M Füssenich, I M E Desar, M E W J Peters, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Health-related quality of life in patients with gastrointestinal stromal tumor: data from a real-world cohort compared with a normative populationD van de Wal, D den Hollander, I M E Desar, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2019
Analysis of 105.000 patients with cancer: have they been discussed in oncologic multidisciplinary team meetings? A nationwide population-based study in the NetherlandsJ E W Walraven, I M E Desar, J J M Hoeven van der, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 13, 2018
Surgical and medical management of small bowel gastrointestinal stromal tumors: A report of the Dutch GIST registryP A Boonstra, N Steeghs, S Farag, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 26, 2025
Double burden: financial toxicity in patients with advanced soft tissue sarcoma at the start of first-line palliative chemotherapy: baseline data from the HOLISTIC studyE Roets, E Younger, R L Jones, et al.
ESMO Open|December 9, 2022
Sex differences in patients with gastrointestinal stromal tumours: do they exist and does it affect survival?N S IJzerman, E van Werkhoven, M Mohammadi, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 17, 2012
Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot studyI M E Desar, E G W ter Voert, Th Hambrock, et al.
Pageof 3